Search results for SEARCH[Study] TILT[Study:StudyFirstPostDate] ALL - ICH GCP

Clinical Trials

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 … 6537 6538 6539 6540 6541 6542 6543 6544 6545 6546 6547 6548 6549 6550 6551 6552 6553 6554 6555 6556 Next Last

NCTID/Status

Study

Last Changed

NCT04239196
Not yet recruiting

Efficacy of Tocilizumab for the Treatment of Acute AION Related to GCA
Conditions: Giant Cell Arteritis; Optic Ischaemic Neuropathy
Intervention: Tocilizumab And IV Steroids Combination, IV Steroids Combination Alone

January 22, 2020

NCT04239183
Not yet recruiting

BE1 Study Spain - CAPSULE SYSTEM FOR COLOSTOMATES
Conditions: Quality of Life of Colostomized Patient
Intervention: Stomatherapy

January 22, 2020

NCT04239170
Recruiting

Camrelizumab(SHR-1210) Combined With GEMOX in Patients With Relapsed or Refractory Hodgkin Lymphoma
Conditions: Hodgkin Lymphoma
Intervention: Camrelizumab(SHR-1210)

January 22, 2020

NCT04239157
Not yet recruiting

Canakinumab and Azacitidine for the Treatment of Low or Intermediate Risk Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia
Conditions: Chronic Myelomonocytic Leukemia; Myelodysplastic Syndrome; Recurrent Chronic Myelomonocytic Leukemia; Recurrent Myelodysplastic Syndrome; Refractory Chronic Myelomonocytic Leukemia; Refractory Myelodysplastic Syndrome
Intervention: Azacitidine, Canakinumab

January 21, 2020

NCT04239144
Recruiting

Sympathetic Denervation by Video-assisted Thoracoscopy in Control of Cardiac Arrhythmias in Patients With Chagas Disease
Conditions: Chagas Cardiomyopathy; Ventricular Arrythmia
Intervention: Left Trunk Sympathectomy, Catheter Ablation

January 20, 2020

NCT04239131
Not yet recruiting

Prospective Study About Sensitization Pattern to Insects as Food Source in Patients With House Dust Mite Allergy
Conditions: Hypersensitivity, Food
Intervention: Skin Prick Test

January 20, 2020

NCT04239118
Completed

New Technologies for Endoscopic Treatment of Bleeding Gastroduodenal Ulcers
Conditions: Ulcer Hemorrhage
Intervention: Complex Endoscopic Treatment With The Use Of Granular Sorbent Aseptisorb-A And Autoplasm Enriched With Platelets, Traditional Methods Of Endoscopic Hemostasis

January 19, 2020

NCT04239105
Not yet recruiting

Detection of Circulating Tumor Cells in Breast Cancer Patients Using a Novel Microfluidic and Raman Spectrum Device
Conditions: Breast Neoplasms; Circulating Tumor Cells
Intervention: Microfluidic And Raman Spectrum

January 19, 2020

NCT04239092
Not yet recruiting

9-ING-41 in Pediatric Patients With Refractory Malignancies.
Conditions: Refractory Cancer; Refractory Neoplasm; Cancer Pediatric; Refractory Tumor; Pediatric Cancer; Pediatric Brain Tumor; Neuroblastoma; Neuroblastoma Recurrent; Pediatric Lymphoma; Pediatric Meningioma
Intervention: 9-ING-41, Irinotecan

January 20, 2020

NCT04239079
Recruiting

Autoimmune Features of Neurodegenerative Disorders
Conditions: Parkinson Disease; Alzheimer Disease; Mild Cognitive Impairment

January 21, 2020

NCT04239066
Active, not recruiting

Penile Ischemia for Hypospadias Repair and The Patients and Surgeons Reported Outcomes
Conditions: Hypospadias; Hypospadias, Coronal; Hypospadia, Repair; Tourniquet
Intervention: Tourniquet, Non-tourniquet

January 20, 2020

NCT04239053
Not yet recruiting

Bupivacaine Levels After ESPB
Conditions: Anesthesia; Bupivacaine Adverse Reaction
Intervention: Bupivacaine

January 22, 2020

NCT04239040
Not yet recruiting

GVAX Plus Checkpoint Blockade in Neuroblastoma
Conditions: Neuroblastoma; Pediatric Solid Tumor
Intervention: Tissue Collection, GVAX Vaccine, Nivolumab, Ipilimumab

January 21, 2020

NCT04239027
Not yet recruiting

A Study to Assess the Effects of Brolucizumab in Adult Patients With Neovascular Age Related Macular Degeneration
Conditions: Neovascular Age Related Macular Degeneration
Intervention: RTH258/Brolucizumab

January 21, 2020

NCT04239014
Not yet recruiting

A Study to Evaluate the Effectiveness and Tolerability of a Second Maintenance Treatment in Participants With Ovarian Cancer, Who Have Previously Received Polyadenosine 5'Diphosphoribose [Poly (ADP Ribose)] Polymerase Inhibitor (PARPi) Treatment.
Conditions: Ovarian Cancer
Intervention: Olaparib, Ceralasertib, Placebo To Match Olaparib

January 21, 2020

NCT04239001
Recruiting

Efficacy and Safety of Pegylated Recombinant Human Granulocyte Stimulating Factor in Secondary Prevention of Albumin Paclitaxel Combined With S-1 in the First-line Treatment of Advanced Pancreatic Cancer
Conditions: Advanced Pancreatic Cancer
Intervention: PEG-rhG-CSF

January 20, 2020

NCT04238988
Not yet recruiting

Carboplatin-Paclitaxel-Pembrolizumab in Neoadjuvant Treatment of Locally Advanced Cervical Cancer
Conditions: Locally Advanced Cervical Cancer
Intervention: Pembrolizumab, Carboplatin, Taxol

January 20, 2020

NCT04238975
Recruiting

A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3111 in Healthy Adults
Conditions: Tetanus; Diphtheria; Whooping Cough
Intervention: GC3111 Vaccine, Boostrix® Vaccine

January 20, 2020

NCT04238962
Not yet recruiting

A Research Study to Compare Two Different Forms of Once-weekly Semaglutide in Two Different Injection Pens
Conditions: Overweight; Obesity
Intervention: Semaglutide (administered By DV3396 Pen-injector), Semaglutide (administered By PDS290 Pen-injector)

January 22, 2020

NCT04238949
Recruiting

Community Health Workers in Pediatric Patients With Newly Diagnosed Type 1 Diabetes
Conditions: Type 1 Diabetes; Diabetes Mellitus; Psychosocial Problem; Compliance, Patient; Health Behavior
Intervention: Community Health Worker Added To Diabetes Team

January 21, 2020

NCT04238936
Active, not recruiting

GDM Patients and Serum Amyloid A and Interleukin-1 (IL-1) Receptor Antagonist
Conditions: Gestational Diabetes
Intervention: Serum Amyloid A Values, Interleukin-1 (IL-1) Receptor Antagonist Values (A-SAA And IL-1Ra)

January 20, 2020

NCT04238923
Not yet recruiting

Topical Gentamicin and Vancomycin for Vascular Surgical Site Infection Prophylaxis
Conditions: Vascular Diseases; Peripheral Vascular Disease; Surgical Site Infection; Bypass Complication
Intervention: Topical Anti Infective Agents

January 22, 2020

NCT04238910
Completed

Maximizing Energy After Traumatic Brain Injury
Conditions: Traumatic Brain Injury; Fatigue
Intervention: Maximizing Energy, Health Education

January 21, 2020

NCT04238897
Completed

To Evaluate the Efficacy and Safety of Aspherical Soft Contact Lens in Myopia Control
Conditions: Myopia
Intervention: Soft Contact Lens

January 19, 2020

NCT04238884
Recruiting

Effectiveness and Efficiency of a Voriconazole Preemptive Genotyping Strategy
Conditions: Invasive Fungal Infections
Intervention: Voriconazole Preemptive Genotyping Strategy, Voriconazole Clinical Practice

January 22, 2020

NCT04238871
Recruiting

PID (RaDiCo Cohort)
Conditions: Idiopathic Interstitial Pneumopathy/Pneumopathy Interstitial Diffuse; Paediatric and Adult Patients

January 20, 2020

NCT04238858
Completed

Effects of Subtenon-injected Autologous Platelet-rich Plasma on Visual Functions in Eyes With Retinitis Pigmentosa
Conditions: Retinitis Pigmentosa
Intervention: Platelet Rich Plasma

January 22, 2020

NCT04238845
Not yet recruiting

Assessment of a Combined Strategy of SMC + Nutrients Supplementation to Tackle Malaria and Malnutrition
Conditions: Malaria; Malnutrition, Child
Intervention: AQSP Administration, Supplementation With Plumpy'Nut®, Supplementation With Vitamin A, Supplementation With Zinc

January 20, 2020

NCT04238832
Not yet recruiting

Salt-Based E-cigarette and IQOS Study
Conditions: Smoking; Tobacco Use
Intervention: Salt Base Nicotine, Free Base Nicotine, IQOS

January 22, 2020

NCT04238819
Not yet recruiting

A Study of Abemaciclib (LY2835219) in Combination With Temozolomide and Irinotecan and Abemaciclib in Combination With Temozolomide in Children and Young Adult Participants With Solid Tumors
Conditions: Relapsed Solid Tumor; Refractory Solid Tumor
Intervention: Abemaciclib, Irinotecan, Temozolomide

January 22, 2020

NCT04238806
Completed

Desflurane,Brain Natriuretic Peptide and Cardiac Surgery
Conditions: Brain Natriuretic Peptide; Coronary Artery Bypass Graft Surgery; Cardiac Surgery; Cardiopulmonary Bypass; Desflurane; Outcome
Intervention: Desflurane Inhalational Agent

January 20, 2020

NCT04238793
Not yet recruiting

Single Ascending Doses Study of KLS-2031 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy
Conditions: Lumbosacral Radiculopathy
Intervention: KLS-2031, Placebo

January 20, 2020

NCT04238780
Not yet recruiting

Erector Spinae Plane Block Reduces Postoperative Pain Following Laparoscopic Colorectal Operation
Conditions: Postoperative Pain
Intervention: Erector Spinae Plane Block

January 20, 2020

NCT04238767
Not yet recruiting

Dolutegravir in Real Life in Lesotho
Conditions: HIV-1-infection
Intervention: Dolutegravir

January 22, 2020

NCT04238754
Not yet recruiting

Oral Cannabidiol for Opioid Withdrawal
Conditions: Opioid Withdrawal; Opioid Craving; Opioid Use Disorder
Intervention: Epidiolex 100 Mg/mL Oral Solution, Cherry Syrup Oral Solution

January 22, 2020

NCT04238741
Completed

Audio-recording of Consent for Anaesthesia for Elective Caesarean Section
Conditions: Caesarean Section; Anesthesia
Intervention: Audio-recording Of Consent For Anaesthesia For Elective Caesarean Section

January 22, 2020

NCT04238728
Not yet recruiting

Silverlon to Reduce Radiation Dermatitis
Conditions: Radiation Dermatitis
Intervention: Silverlon

January 21, 2020

NCT04238715
Not yet recruiting

A Study of E7090 in Participants With Unresectable Advanced or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor (FGFR) 2 Gene Fusion
Conditions: Cholangiocarcinoma
Intervention: E7090

January 22, 2020

NCT04238702
Not yet recruiting

Renohemodynamic Effects of Combined empagliflOzin and LosARtan
Conditions: Diabetes Mellitus, Type 2; Diabetic Kidney Disease
Intervention: Empagliflozin 10 MG, Losartan 50Mg Tab, Placebo

January 21, 2020

NCT04238689
Recruiting

Safety, Tolerability, and Pharmacokinetics and Pharmacodynamics of TB31F
Conditions: Malaria,Falciparum
Intervention: TB31F

January 22, 2020

NCT04238676
Not yet recruiting

Persica 002 Phase 1b PP353 vs Placebo in the Treatment of Low Back Pain
Conditions: Chronic Low-back Pain
Intervention: PP353, PP353-B

January 22, 2020

NCT04238663
Active, not recruiting

Pharmacokinetic Study Comparing MB02 And US And EU Avastin® In Healthy Male Volunteers
Conditions: Healthy Volunteers
Intervention: MB02 (Bevacizumab Biosimilar), EU Approved Avastin®, US Licenced Avastin®

January 20, 2020

NCT04238650
Completed

A Pharmacokinetic Study Comparing MB02 And EU Avastin® In Healthy Male Volunteers
Conditions: Japanese Healthy Male Volunteers
Intervention: MB02 (Bevacizumab Biosimilar), EU Approved Avastin®

January 20, 2020

NCT04238637
Recruiting

Immunotherapy Combined With Y-90 SIRT Therapy in Advanced Stage Intrahepatic Biliary Tract Cancer (BTC)
Conditions: Intrahepatic Cholangiocarcinoma
Intervention: Durvalumab, Tremelimumab

January 22, 2020

NCT04238624
Recruiting

Study of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid Cancer
Conditions: Anaplastic Thyroid Cancer; Thyroid Cancer; BRAF Gene Mutation; BRAF Mutation-Related Tumors
Intervention: Dabrafenib, Trametinib

January 21, 2020

NCT04238611
Not yet recruiting

Minimally-Invasive Realtime Assessment of Continuous Lactate in Exercise
Conditions: Exercise; Lactate
Intervention: Microneedle, Blood Lactate Measurement, Exercise Regimen

January 22, 2020

NCT04238598
Recruiting

Intra-articular Pulsed Radiofrequency Neuromodulation Versus Intra-articular Steroids for Painful Knee Osteoarthritis
Conditions: Knee Osteoarthritis
Intervention: Pulse Radiofrequency, Standard Of Care Intra- Articular Injection, Placebo Intra-Articular Injection

January 22, 2020

NCT04238585
Not yet recruiting

BabyQ's: Randomized Controlled Trial of Health Messaging in Pregnancy and Infancy
Conditions: Pregnancy Related; Infant Development
Intervention: Mobile Messaging

January 22, 2020

NCT04238572
Not yet recruiting

Evaluation of Immersive Audiovisual Distraction Impact on Peroperative Opioid Consumption.
Conditions: Surgical Procedure, Unspecified; Analgesia; Outpatient
Intervention: Audiovisual Distraction Device, Analgesia Nociception Index

January 22, 2020

NCT04238559
Completed

Use of the SWAMECO Questionnaire Basel
Conditions: Swallowing Difficulties
Intervention: Self-report Questionnaire

January 20, 2020

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 … 6537 6538 6539 6540 6541 6542 6543 6544 6545 6546 6547 6548 6549 6550 6551 6552 6553 6554 6555 6556 Next Last

Last Updated

The last updated date is the most recent date when changes to a clinical trial were submitted to ClinicalTrials.gov. There is often a delay of a few days before the updated trial is available on the clinical trials website.

Specify a From date to find the most recently changed trials. Specify both From and To dates to find trials changed during a certain period. If no dates are given, all trials will be included.

Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.

First Received

The first received date is the date when the clinical trial was first submitted to ClinicalTrials.gov. There is often a delay of a few days before the trial is available on the clinical trials website.

Clinical trial records are often updated after they have been published. The first received, last updated, start, and end dates are all displayed in the full text view of the clinical trial.

Specify a From date to find the most recent trials. Specify both From and To dates to find trials submitted during a certain period. If no dates are given, all trials will be included.

Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.

Safety Issue

If selected, restricts search results to those studies which have an outcome measure designated as a safety issue. Note that this is a poor estimate of the safety of a treatment or intervention, but it is all we have now.

Funded By

Studies are supported by one or more organizations called sponsors. Support includes contributions of facilities, expertise, and/or financial resources. All sponsors in the database have been assigned one of the following organization types:

National Institutes of Health (NIH)

Other U.S. Federal Agency - Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), Department of Veterans Affairs (VA), etc.

Industry - the pharmaceutical companies

University/Organization - all others, including community-based organizations

Click the check box to the left of each organization type that you wish to include in your search. You can select more than one organization type. If you do not select any type, all types will be included.

Study Phase

Most clinical trials are designated as phase 1, 2, 3, or 4, based on the type of questions that study is seeking to answer:

In Phase 1 (Phase I) clinical trials, researchers test a new drug or treatment in a small group of people (20-80) for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.

In Phase 2 (Phase II) clinical trials, the study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety.

In Phase 3 (Phase III) clinical trials, the study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.

In Phase 4 (Phase IV) clinical trials, post marketing studies delineate additional information including the drug's risks, benefits, and optimal use.

These phases are defined by the Food and Drug Administration in the Code of Federal Regulations.

Click the check box to the left of each study phase that you wish to include in your search. You can select more than one study phase. If you do not select a any phase, all phases will be included.

Age Group

Studies may be designed for participants of particular ages:

Children (birth-17 yrs old)

Adults (18-65 yrs old)

Senior (66+ yrs old)

Click the check box to the left of each age group that you wish to include in your search. You can select more than one age group. If you do not select a any group, all groups will be included.

Gender

Searches can be restricted to studies which accept female or male participants.

Location Terms

If you are interested in a specific city (such as Los Angeles) or facility name (such as the Mayo Clinic), enter it as a location term. Not all studies include this level of detail, but if they do, this will find them.

Countries and States

Trials are often conducted at many locations around the world. Select up to three locations to find trials conducted in specific countries. Some countries (currently limited to the United States, Canada, and Australia), locations can be narrowed further by selecting a state.

Study IDs

Each trial is assigned one or more identification numbers by the institute, agency, or organization sponsoring the trial. In addition, clinical trials assigns a unique NCT identifier of the form NCTxxxxxxxx where each x is a numeric digit. Use this box to search for a trial by NCT identifier or any other study identification numbers.

Examples:

NCT00001789
97-h-0197
ia0006
actg 076

Sponsor (Lead)

Use this box to specify the name of an institute, organization, or company that is conducting a trial.

It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.

A search in this area will check only the sponsor field. To also look for collaborators, use the Sponsor/Collaborators search box.

When the Exact Match checkbox is checked, the sponsor name in the study must exactly match the sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.

Examples:

National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb

Sponsor/Collaborators

Use this box to specify institutes, organizations, or companies that are conducting or otherwise supporting a trial.

It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.

Searching this area will look in both the sponsor field and in the collaborators field. To only look in the sponsor field, use the Sponsor (Lead) search box.

When the Exact Match checkbox is checked, the name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.

Examples:

National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb

Outcome Measures

Outcome measures are used to evaluate trial results. For example, an obesity treatment might be evaluated by a measure of weight loss after 6 months. Measures can also be used to quantify side effects, such as number of myocardial infarctions, number of patients with heart arrhythmia, number of suicides, etc.

Use this box to specify an outcome measure used to evaluate trial results.

Examples:

weight loss
heart failure
suicide

Interventions

Interventions refer to the drug, vaccine, procedure, device, or other potential treatment being studied. Interventions can also include less intrusive possibilities such as surveys, education, and interviews.

Use this box to specify drugs, devices, procedures, or vaccines used in a trial.

Examples:

clofibrate
cyclosporine
vitamin e

Conditions

Conditions usually refer to a disease, disorder, syndrome, illness, or injury. In ClinicalTrials.gov, conditions include any health issue worth studying, such as lifespan, quality of life, health risks, etc.

Use this box to specify the conditions being studied.

Examples:

lupus
heart attack
leukemia
risk factors for breast cancer

Study Type

There are three types of studies available in ClinicalTrials.gov:

Interventional:

Studies where individuals are assigned to receive specific interventions. Participants may receive diagnostic, therapeutic or other types of interventions. Assignment of the intervention may or may not be random. Individuals are tracked and biomedical and/or health outcomes are assessed.

Observational:

Studies without an intervention. Studies where biomedical and/or health outcomes are assessed in a pre-defined group of individuals. Participants may receive diagnostic, therapeutic, or other interventions, but the investigator does not assign specific interventions to the participants of the study.

Expanded Access:

Records describing the procedure for obtaining an experimental drug or device for patients who are failing on currently available treatments for their condition and also are unable to participate in ongoing clinical trials. Expanded Access records are used to register all types of non-protocol access to experimental treatments, including protocol exception, single-patient IND, treatment IND, compassionate use, emergency use, continued access and parallel track.

Study Results

Searches can be restricted to studies with or without results.

The inclusion of study results is a relatively new feature of ClinicalTrials.gov. Collection of results began in September of 2008. Almost all older studies and some newer studies do not include results. As time goes on, there will be more results available.

Recruitment Status

Also known as Enrollment Status.

Not all clinical trials in this database are accepting new participants. If you are looking for studies that are currently recruiting participants, will be recruiting in the future, or are about drugs that are available for expanded access, select Open Studies in the recruitment menu.

If you are interested in all trials, whether they are recruiting new participants or not, leave the menu with All Studies selected.

Trials may not be recruiting because they are full, completed, or halted for various reasons. In addition, some trials have very restrictive eligibility requirements and must seek participants by invitation only. To see these studies, Select Closed Studies in the recruitment menu.

Full list of all possible recruitment status values:

Open recruitment status values:

Recruiting,
Not yet recruiting, or
Available for expanded access.

Closed recruitment status values:

Active, not recruiting,
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.

Values are color coded (as shown) in the search results.

Search Terms

Use this box to specify general search terms found anywhere in the trial record.

Multiple terms can be separated by an AND (all uppercase).

Examples:

type ii diabetes
veterans affairs medical center
heart attacks in older adults
nhlbi AND heart disease
Cisplatin AND safety study

Help for Searching clinical trials

Help Topics:

Basic Search
Advanced Search
Refine Search
Search Expressions

Basic Search:

On the Basic Search page, enter a word or word(s) that you want to use to find studies. These may include diseases, interventions, and/or locations.

Medical terms are often several words long, such as Percutaneous Coronary Intervention. To only find studies where the words are together as a phrase, put the term in quotes (e.g., "Percutaneous Coronary Intervention"). If you search for a multi-word term without quotes, studies with all words together as a phrase will appear higher in the results list than studies where the words are separated and spread throughout the document. For example, a search for Heart Attack will list a study about,

Use of a Pacemaker Following a Heart Attack.

higher than the study,

Heart Defects and Transient Ischemic Attacks

A search for "Heart Attack" would not find the second study. Synonyms are known for some terms and are used where possible. For example, a search for Heart Attack will also find occurrences of Myocardial Infarction.

Advanced Search:

Many searches are a single term and can be performed with a few words in the search box. But, sometimes you need more control. Click on the Advanced Search tab (if starting a new search) or Refine Search tab (if modifying an existing search) to show additional search fields.

The additional search fields can be used to limit your search results. Note that it is not necessary to fill in all the fields, only those that are needed for your search. If you are finding too few studies, consider clearing a field and searching again.

Search Terms:

Performs a general search in all sections of the study record, including title, description, conditions, interventions, locations, etc. Terms in this field are searched the same as Basic Search.

Recruitment:

Limits search results to studies that are open or closed. New volunteers may be able to participate in open studies, but not closed studies.

Open recruitment status values:

Recruiting,
Not yet recruiting, or
Available for expanded access.

Closed recruitment status values:

Values are color coded (as shown) in the search results.

Study Results:

Limits search results based on whether the study has results or not:

All Studies,
Studies With Results, or
Studies Without Results

The inclusion of Study Results is a new feature of ClinicalTrials.gov. Only a few studies have results available.

Study Type:

Limits search results to any of the following study types:

Interventional,
Observational, or
Expanded Access

Conditions:

Performs a search on fields describing the diseases or conditions being studied.

Interventions:

Performs a search on fields listing the drugs or interventions being studied.

Outcomes Measures:

Performs a search on fields listing the outcome measures used to quantify study results.

Sponsor/Collaborators:

Performs a search on fields listing the sponsor and collaborators of a study.

When the Exact Match checkbox is checked, the sponsor/collaborator name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck in the sponsor/collaborator field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.

Sponsor (Lead):

Performs a search on the sponsor field of a study.

It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the "sponsor" is decided by the data provider.

When the Exact Match checkbox is checked, the lead sponsor name in the study must exactly match the lead sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.

Study IDs:

Performs a search on fields listing ID numbers.

Country/State:

Location Terms:

Finds studies in specific locations such as a city (Los Angeles) or facility (Mayo Clinic). Not all studies include this level of detail, but if they do, this will find them.

Gender:

Limits search results to those studies that accept female or male participants.

Age Group:

Limits search results to those studies that include at least one of the specified age ranges. More than one age group can be selected.

Phase:

Limits search results to studies that are labeled with at least one of the specified phases. More than one Phase can be selected.

Funded By:

Limits search results to studies that have at least one sponsor of the specified types. More than one sponsor type can be selected.

Safety Issue:

Limits search results to studies that have at least one outcome measure designated as a safety issue.

First Received:

Limits search results to studies that were received by clinical trials within a specified date range. The "From" or "To" field can be left blank.

Last Updated:

Limits search results to studies that were modified within a specified date range. The "From" or "To" field can be left blank.

Refine Search:

Searches display a list of studies found (List Results tab). If you are not content with the search results, click on the Refine Search tab at the top of the list to modify your search.

Add terms to empty fields to search within your current result. You can also add terms to fields that contain terms. For best results, use an AND (all upper case) as a separator between terms in the same field.

For example:

heart attack
heart attack AND aspirin
heart attack AND aspirin AND older adults
heart attack AND aspirin AND older adults AND California

When you are done making changes, click Search to display the new results.

Search Expressions:

Use AND (all upper case) to find study records that contain all terms connected by AND.
For example:

prostate cancer AND radiation
heart disease AND stroke AND California

Use OR (all upper case) to find study records that contain either term connected by OR.
For example:

Aspirin OR ibuprofen
heart disease OR heart attack

Use NOT (all upper case) to find study records that do not contain the term following NOT.
For example:

Immunodeficiency NOT AIDS

Likewise, AND, OR, NOT, and parentheses can be used to create more complicated search expressions.
For example:

prostate cancer AND NOT ( radiation OR homeopathic remedies )
( heart disease OR heart attack ) AND ( stroke OR clot )

Note that the use of AND and OR as logical operators can be confusing.
An appropriate search for a list such as,

Ear, Nose, and Throat Conditions

is the expression

( Ear OR Nose OR Throat ) AND Conditions

Fortunately, search will do a pretty good job of finding the right studies either way.

To search for AND as a word, instead of using it as an operator, put it in quotes.
Likewise, you can quote OR, NOT, and parentheses.

ICH GCP | Clinical Trials Registry

Clinical Trials

Fill in any or all of the fields below.

Conditions

Rare Diseases

Drug
Interventions

Dietary
Supplements

Sponsor/
Collaborators

Locations

ICH GCP | Clinical Trials Registry

Clinical Trials

Fill in any or all of the fields below.

Conditions

Rare Diseases

DrugInterventions

DietarySupplements

Sponsor/Collaborators

Locations

Drug
Interventions

Dietary
Supplements

Sponsor/
Collaborators